Atlas Trials

Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure

Clinical trial NCT05598333 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05598333
Sponsor
AskBio Inc
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Congestive Heart Failure
Start date
2023-10-20
Primary completion
2026-10-31
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.